“…The second school advocates an optimum cut off point, above which prognosis significantly falls [11,15,17,22,71], of 4 lymph nodes (reported range: 3-7 involved lymph nodes) [13, 14, 41, 54, 57, 71, 79, 87, 94 95]. When comparing patients with greater than four involved lymph nodes to those with four or less involved lymph nodes, the risk of developing recurrent disease rises from 45% to 82% and the 5-year survival is significantly reduced [13,22,71,87,89]. Median survival with 1-4 involved lymph nodes is 33 months (95% CI: 28-37 months) but this falls to 17 months (95% CI: 16-19 months) for patients with greater than 4 involved lymph nodes (87).…”